Quick Answer
Edesa Biotech, Inc. reported R&D Expense of $3.67 million for fiscal year 2025.
Edesa Biotech, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $3.67M | +27.3% |
| 2024 | $2.88M | -39.9% |
| 2023 | $4.79M | -64.0% |
| 2022 | $13.34M | -25.7% |
| 2021 | $17.95M | +439.0% |
| 2020 | $3.33M | +59.5% |
| 2018 | $2.09M | +5.8% |
| 2017 | $1.97M | +14.1% |
| 2016 | $1.73M | +68.0% |
| 2015 | $1.03M | +477.5% |
| 2014 | $178.3K | -92.7% |
| 2014 | $2.46M | +21.8% |
| 2013 | $2.02M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $1.12M | +10.3% | +19.8% |
| June 30, 2025 | $939.1K | +4.7% | +93.9% |
| March 31, 2025 | $484.3K | -58.8% | -52.5% |
| December 31, 2024 | $1.02M | +44.8% | +13.7% |
| June 30, 2024 | $897.3K | -12.5% | -23.7% |
| March 31, 2024 | $1.18M | -19.3% | +67.0% |
| December 31, 2023 | $704.5K | -48.1% | -31.3% |
| June 30, 2023 | $1.03M | -77.4% | -29.7% |
- Edesa Biotech, Inc. showed an increase of +27.3% in R&D Expense compared to the prior fiscal year.
- Over the 2013–2025 period, Edesa Biotech, Inc.’s r&d expense has grown by 81.8% (from $2.02 million to $3.67 million).
- The most recent figure is from Edesa Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 12, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: